Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etanercept and Mifepristone for Gulf War Illness
NCT04254627Phase 1Completed
- Sponsor
- Nova Southeastern University
- Start
- Sep 2021
- Primary completion
- Sep 2025
- Modality
- Orthosteric Ligands, Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of etanercept and mifepristone in Gulf War illness (GWI) (2 arms), sponsored by Nova Southeastern University. Primary endpoints: Incidence and severity of adverse events at 16 weeks and Mechanistic effects on biomarker relationships at 24 weeks. Started Sep 2021; status: completed.
02
Drugs
etanerceptmifepristone
03
Conditions
Gulf War illness (GWI)
Beyond the preview
Go deeper on NCT04254627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04254627.